Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Amps Up "Name And Shame" Approach To Thwart Anti-Generic Tactics

Oct 03 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

FDA's Generic Policy Initiative Includes Choose-Your-Own-Agenda Meeting

Jun 22 2017

Will CBO Score CREATE Momentum For Generic Bill's Passage?

Sep 19 2018

REMS Abuse Website: All Sizzle, No Steak?

Sep 06 2018

Citizen Petitions Targeting ANDAs Recede, But Concerns Over Resources Remain

Aug 19 2016

Additional Topics

United States Generic Drugs Legal Issues Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window